Bio Pharma Buffer Market by Type (Phosphates, Acetates, TRIS, Others), Application, Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025
Published On: May 2019
 
Report ID:386005
 
Category: Healthcare
 
Pages: N/A




Global bio pharma buffer market is expected to reach USD 980.78 Million by 2025, at a CAGR of 7.41% from 2018 to 2025. Growing demand for vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy are driving the global bio pharma buffer market.

Market Overview:

A buffer solution is comprised of a weak conjugate acid-base pair. For example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists the changes in pH. Solutions with stable pH are obligatory for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.

Report Description:

  • The base year for the study has been considered 2017, historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global bio pharma buffer market is analysed on the basis of value (USD Million), volume (Kilotons), consumption (Kilotons), imports (Kilotons) and exports (Kilotons).
  • The study delivers a comprehensive analysis of global bio pharma buffer market by type, application and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global bio pharma buffer market. This report incorporates the industry analysis which is focused on providing an extensive view of the bio pharma buffer market.
  • The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the bio pharma buffer market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Growing demand for blood and blood plasma for transfusion purposes
  • Global ongoing vaccination program against polio, rubella and other such diseases

Restrains:

  • Highly competitive nature of the market

Opportunities:

  • Growing research and development activities for the finding the newer vaccines
  • Ongoing research activities in the gene therapy and cell therapy fields

Challenges:

  • Concerns related to toxicity of certain buffer solutions

Global Bio Pharma Buffer Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global bio pharma buffer market has been segmented on the basis of type and application.

  • Type segment is divided into phosphates, acetates, TRIS, and others. Phosphate buffer solution is a buffer solution widely used for the purposes of biological research. It is a water-based salt solution containing disodium hydrogen phosphate, sodium chloride and, in some formulations, potassium chloride, and potassium dihydrogen phosphate. Whereas TRIS buffer solutions are used to dilute substances used in laboratory experiments due to their isotonic and non-toxic properties.
  • Application segment is divided into research institutions, pharmaceutical industry and other. Pharmaceutical industry emerged as the largest application segment with a 53.19% share of market revenue in 2017. Growing demand for the biopharmaceuticals such as vaccines, antibodies, hormones are the factors that are propelling this increased market share.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region emerged as the largest market for the bio pharma buffer with a 41.34% share of market revenue in 2017.

  • Presence of leading pharmaceutical manufacturers, well-developed medical and healthcare sector, as well as robust demand for the biopharmaceuticals, were the factors that led the North America region to emerge as the dominant market in 2017.
  • Asia Pacific region is anticipated to grow at an accelerated CAGR of 9.53% over the forecast period. This increased growth can be attributed to the rapid development of the pharmaceuticals industry as well as increased government spending on improving the standards of the healthcare facilities coupled with the implementation of massive immunization programs in the region.

Global Bio Pharma Buffer Market Competitive Analysis:

Key players in the global bio pharma buffer market are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL. Biopharm International, among others. Major players are effectively competing in the market with their wide array of bio pharma buffer solutions. For instance Avantor, has developed J.T.Baker® and Macron Fine Chemicals™ brands of buffering salts. These buffering salts are manufactured using cGMP processes and maximize the stability of the biopharmaceutical formulations by delivering predictable pH control.

*All our reports are customizable as per customer requirements

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global bio pharma buffer market on the basis of below mentioned segments:

Global Bio Pharma Buffer Market by Type:

  • Phosphates
  • Acetates
  • TRIS
  • Others

Global Bio Pharma Buffer Market by Application:

  • Research Institution
  • Pharmaceutical Industry
  • Others

Global Bio Pharma Buffer Market by Region:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Sweden
  • Netherlands
  • U.K.
  • Italy
  • Spain
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of  Middle East and Africa

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market Attractiveness Analysis By Type
        4.3.2. Market Attractiveness Analysis By Application
        4.3.3. Market Attractiveness Analysis By Region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Growing demand for blood and blood plasma for transfusion purposes
        5.2.2. Global ongoing vaccination program against polio, rubella and other such diseases
   5.3. Restraints
        5.3.1. Highly competitive nature of the market
   5.4. Opportunities
        5.4.1. Growing research and development activities for the finding the newer vaccines
        5.4.2. Ongoing research activities in the gene therapy and cell therapy fields
   5.5. Challenges
        5.5.1. Concerns related to toxicity of certain buffer solutions


6. Global Bio Pharma Buffer Market Analysis and Forecast, By Type
   6.1. Segment Overview
   6.2. Phosphates
   6.3. Acetates
   6.4. TRIS
   6.5. Others

7. Global Bio Pharma Buffer Market Analysis and Forecast, By Application
   7.1. Segment Overview
   7.2. Research Institution
   7.3. Pharmaceutical Industry
   7.4. Others

8. Global Bio Pharma Buffer Market Analysis and Forecast, By Regional Analysis
   8.1. Segment Overview
   8.2. North America
        8.2.1. U.S.
        8.2.2. Canada
        8.2.3. Mexico
   8.3. Europe
        8.3.1. Germany
        8.3.2. France
        8.3.3. Sweden
        8.3.4. Netherlands
        8.3.5. U.K.
        8.3.6. Italy
        8.3.7. Spain
        8.3.8. Turkey
        8.3.9. Switzerland
        8.3.10. Belgium
        8.3.11. Rest of Europe
   8.4. Asia-Pacific
        8.4.1. Japan
        8.4.2. China
        8.4.3. India
        8.4.4. South Korea
        8.4.5. Australia
        8.4.6. Singapore
        8.4.7. Malaysia
        8.4.8. Thailand
        8.4.9. Indonesia
        8.4.10. Philippines
        8.4.11. Rest of Asia-Pacific
   8.5. South America
        8.5.1. Brazil
        8.5.2. Argentina
        8.5.3. Colombia
        8.5.4. Rest of South America
   8.6. Middle East and Africa
        8.6.1. Saudi Arabia
        8.6.2. UAE
        8.6.3. Egypt
        8.6.4. Nigeria
        8.6.5. South Africa
        8.6.6. Rest of  Middle East and Africa

9. Global Bio Pharma Buffer Market-Competitive Landscape
   9.1. Overview
   9.2. Market Share of Key Players in the Bio Pharma Buffer Market
        9.2.1. Global Company Market Share
        9.2.2. North America Company Market Share
        9.2.3. Europe Company Market Share
        9.2.4. APAC Company Market Share
   9.3. Competitive Situations and Trends
        9.3.1. Product Launches and Developments
        9.3.2. Partnerships, Collaborations, and Agreements
        9.3.3. Mergers & Acquisitions
        9.3.4. Expansions

10. Company Profiles
   10.1. Avantor
        10.1.1. Business Overview
        10.1.2. Company Snapshot
        10.1.3. Company Market Share Analysis
        10.1.4. Company Product Portfolio
        10.1.5. Recent Developments
        10.1.6. SWOT Analysis
   10.2. Alfa Aesar (Thermo Fisher)
        10.2.1. Business Overview
        10.2.2. Company Snapshot
        10.2.3. Company Market Share Analysis
        10.2.4. Company Product Portfolio
        10.2.5. Recent Developments
        10.2.6. SWOT Analysis
   10.3. Merck
        10.3.1. Business Overview
        10.3.2. Company Snapshot
        10.3.3. Company Market Share Analysis
        10.3.4. Company Product Portfolio
        10.3.5. Recent Developments
        10.3.6. SWOT Analysis
   10.4. , Lonza
        10.4.1. Business Overview
        10.4.2. Company Snapshot
        10.4.3. Company Market Share Analysis
        10.4.4. Company Product Portfolio
        10.4.5. Recent Developments
        10.4.6. SWOT Analysis
   10.5. Bio-Rad
        10.5.1. Business Overview
        10.5.2. Company Snapshot
        10.5.3. Company Market Share Analysis
        10.5.4. Company Product Portfolio
        10.5.5. Recent Developments
        10.5.6. SWOT Analysis
   10.6. BD
        10.6.1. Business Overview
        10.6.2. Company Snapshot
        10.6.3. Company Market Share Analysis
        10.6.4. Company Product Portfolio
        10.6.5. Recent Developments
        10.6.6. SWOT Analysis
   10.7. GE Healthcare
        10.7.1. Business Overview
        10.7.2. Company Snapshot
        10.7.3. Company Market Share Analysis
        10.7.4. Company Product Portfolio
        10.7.5. Recent Developments
        10.7.6. SWOT Analysis
   10.8. Promega Corporation
        10.8.1. Business Overview
        10.8.2. Company Snapshot
        10.8.3. Company Market Share Analysis
        10.8.4. Company Product Portfolio
        10.8.5. Recent Developments
        10.8.6. SWOT Analysis
   10.9. Hamilton Company
        10.9.1. Business Overview
        10.9.2. Company Snapshot
        10.9.3. Company Market Share Analysis
        10.9.4. Company Product Portfolio
        10.9.5. Recent Developments
        10.9.6. SWOT Analysis
   10.10. XZL BIO-TECHNOLOGY
        10.10.1. Business Overview
        10.10.2. Company Snapshot
        10.10.3. Company Market Share Analysis
        10.10.4. Company Product Portfolio
        10.10.5. Recent Developments
        10.10.6. SWOT Analysis
   10.11. SRL., Biopharm International
        10.11.1. Business Overview
        10.11.2. Company Snapshot
        10.11.3. Company Market Share Analysis
        10.11.4. Company Product Portfolio
        10.11.5. Recent Developments
        10.11.6. SWOT Analysis

 


List of Figures 

1. Global Bio Pharma Buffer Market Segmentation

2. Bio Pharma Buffer Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Bio Pharma Buffer Market Attractiveness Analysis By Type

9. Global Bio Pharma Buffer Market Attractiveness Analysis By Application

10. Global Bio Pharma Buffer Market Attractiveness Analysis By Region

11. Global Bio Pharma Buffer Market: Dynamics

12. Global Bio Pharma Buffer Market Share By Type (2017 & 2025)

13. Global Bio Pharma Buffer Market Share By Application (2017 & 2025)

14. Global Bio Pharma Buffer Market Share By Regions (2017 & 2025)

15. Global Bio Pharma Buffer Market Share By Company (2018)

 

List of Table

1. Global Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

2. Global Phosphates Bio Pharma Buffer Market, Region, 2015–2025 (USD Million) (Kilotons)

3. Global Acetates Bio Pharma Buffer Market, Region, 2015–2025 (USD Million) (Kilotons)

4. Global TRIS Bio Pharma Buffer Market, Region, 2015–2025 (USD Million) (Kilotons)

5. Global Others Bio Pharma Buffer Market, Region, 2015–2025 (USD Million) (Kilotons)

6. Global Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

7. Global Research Institutions Bio Pharma Buffer Market, By Region, 2015–2025 (USD Million) (Kilotons)

8. Global Pharmaceuticals Industry Bio Pharma Buffer Market, By Region, 2015–2025 (USD Million) (Kilotons)

9. Global Others Bio Pharma Buffer Market, By Region, 2015–2025 (USD Million) (Kilotons)

10. Global Bio Pharma Buffer Market, By Region, 2015–2025 (USD Million) (Kilotons)

11. North America Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

12. North America Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

13. U.S. Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

14. U.S. Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

15. Canada Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

16. Canada Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

17. Mexico Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

18. Mexico Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

19. Europe Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

20. Europe Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

21. Germany Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

22. Germany Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

23. France Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

24. France Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

25. Sweden Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

26. Sweden Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

27. Netherlands Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

28. Netherlands Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

29. U.K. Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

30. U.K. Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

31. Italy Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

32. Italy Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

33. Spain Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

34. Spain Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

35. Turkey Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

36. Turkey Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

37. Switzerland Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

38. Switzerland Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

39. Belgium Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

40. Belgium Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

41. Asia Pacific Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

42. Asia Pacific Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

43. Japan Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

44. Japan Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

45. China Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

46. China Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

47. India Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

48. India Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

49. South Korea Bio Pharma Buffer Market, By v, 2015–2025 (USD Million) (Kilotons)

50. South Korea Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

51. Australia Bio Pharma Buffer Market, By v, 2015–2025 (USD Million) (Kilotons)

52. Australia Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

53. Singapore Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

54. Singapore Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

55. Malaysia Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

56. Malaysia Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

57. Thailand Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

58. Thailand Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

59. Indonesia Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

60. Indonesia Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

61. Philippines Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

62. Philippines Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

63. South America Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

64. South America Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

65. Brazil Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons) 

66. Brazil Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

67. Argentina Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

68. Argentina Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

69. Colombia Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

70. Colombia Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

71. Middle East and Africa Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

72. Middle East and Africa Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

73. Saudi Arabia Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

74. Saudi Arabia Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

75. UAE Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

76. UAE Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

77. Egypt Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

78. Egypt Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons) 

79. Nigeria Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

80. Nigeria Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)

81. South Africa Bio Pharma Buffer Market, By Type, 2015–2025 (USD Million) (Kilotons)

82. South Africa Bio Pharma Buffer Market, By Application, 2015–2025 (USD Million) (Kilotons)



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.